Digital AI and the Big Data paradigm – big ambitions in novel drug d... Over the past few decades, data generation has veritably exploded.
Digital It’s time for more tech and biotech innovation in 2023 The drive to make the UK a ‘scientific powerhouse’ was central to the government’s
Digital A few of 2022’s biggest pharma trends – the pharmaphorum pod... As we close out the year, pharmaphorum's editorial team sat down together for a roundtable discussion of some of the biggest trends they tracked this year in the world of
Digital Curavit’s crystal ball – how will 2023 drive meaningful chan... The life sciences industry is flexing towards innovation in new areas, faster than ever before, and increasing patient care in astonishing ways.
News AI innovator Quris seed funding grows to $37 million Quris, an artificial intelligence (AI) innovator in the pharmaceutical arena, has secured an additional $9 million in seed funding, expanding its
Cancer Targeting the ecosystem to make cancer extinct The ICR and The Royal Marsden have embarked on an ambitious research collaboration to disrupt the cancer cell ecosystem.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
